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whose stability and function are modulated by membrane cholesterol. The recent high-resolution crystal structure of the
b2-adrenergic receptor revealed the presence of possible cholesterol-binding sites in the receptor. However, the functional
relevance of cholesterol binding to the receptor remains unexplored. We used MARTINI coarse-grained molecular-dynamics
simulations to explore dimerization of the b2-adrenergic receptor in lipid bilayers containing cholesterol. A novel (to our knowl-
edge) aspect of our results is that receptor dimerization is modulated by membrane cholesterol. We show that cholesterol binds
to transmembrane helix IV, and cholesterol occupancy at this site restricts its involvement at the dimer interface. With increasing
cholesterol concentration, an increased presence of transmembrane helices I and II, but a reduced presence of transmembrane
helix IV, is observed at the dimer interface. To our knowledge, this study is one of the first to explore the correlation between
cholesterol occupancy and GPCR organization. Our results indicate that dimer plasticity is relevant not just as an organizational
principle but also as a subtle regulatory principle for GPCR function. We believe these results constitute an important step toward
designing better drugs for GPCR dimer targets.INTRODUCTIONThe G-protein-coupled receptor (GPCR) superfamily com-
prises the largest group of integral membrane proteins in
mammals and is involved in information transfer (signal
transduction) across cellular membranes (1–3). GPCRs are
typically seven-transmembrane-domain proteins and
include >800 members that are encoded by ~5% of human
genes (4). GPCRs are important drug targets due to their
central role in cellular signaling, and it is estimated
that ~50% of clinically prescribed drugs target GPCRs
(5,6). An emerging and exciting area in GPCR research is
oligomerization of GPCRs and the possible role of oligo-
merization in GPCR function and signaling (7–11). The
potential implications of such oligomerization are far-reach-
ing, particularly in the context of GPCRs as major drug
targets (12–14). GPCR oligomerization implies an increased
cross talk between receptors via homo- and/or heterodimers
as well as higher-order oligomers (10,13,15). Interestingly,
membrane lipids were recently implicated in the modulation
of GPCR oligomerization (15,16).
Membrane cholesterol has been shown to influence the
organization, stability, and function of several GPCRs,
including rhodopsin (17), the b2-adrenergic receptor
(18–20), and the serotonin1A receptor (21–26). The spatial
organization of GPCRs such as the serotonin1A receptor,
including both dimerization and higher-order oligomeriza-
tion, has been reported to be influenced by membrane
cholesterol (16,17). It has been speculated that cholesterol
alters GPCR function and organization by either direct inter-
actions with the receptor or indirect alterations of membraneSubmitted July 15, 2013, and accepted for publication February 3, 2014.
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number of recently solved high-resolution crystal structures
of GPCRs, such as the b1-adrenergic receptor (28),
b2-adrenergic receptor (29,30), and A2A adenosine receptor
(31), is the close association between cholesterol molecules
and the receptor. Recent molecular-dynamics simulations
revealed cholesterol-binding sites in GPCRs, although rela-
tively weak interactions were observed (32–34). However,
despite the increasing number of reports regarding a
GPCR-cholesterol interaction, the exact role of cholesterol
at the molecular level in GPCR structure and function
continues to be elusive.
The b2-adrenergic receptor is an important member of the
GPCR superfamily and serves as an excellent prototype for
monitoring GPCR organization and function. This receptor
type is expressed mainly in muscle tissues. The b2-adren-
ergic receptor is involved in muscle relaxation after activa-
tion (35) and dysfunction of this receptor is associated with
cardiac diseases and asthma (36,37). It was reported that the
b2-adrenergic receptor can exist as dimers in vivo (38), and
dimerization is functionally important (39), although a
monomeric receptor was shown to be the minimal func-
tional unit necessary for signaling (40). A direct receptor-
cholesterol interaction was revealed by the cocrystallization
of cholesterol in the crystal structure of the b2-adrenergic
receptor (30). In addition, receptor function was shown to
be dependent on membrane cholesterol (19,20). Yet, the
molecular relevance of cholesterol’s association with the
receptor is still not clear.
In this work, we carried out coarse-grained molecular-
dynamics simulations to analyze the molecular nature of
the interaction between membrane cholesterol and the
b2-adrenergic receptor, and explore the effect of cholesterolhttp://dx.doi.org/10.1016/j.bpj.2014.02.002
Cholesterol and Receptor Dimerization 1291on the dimerization of the receptor. We simulated the
b2-adrenergic receptor in a 1-palmitoyl-2-oleoyl-sn-
glycero-3-phosphocholine (POPC) membrane bilayer in
the presence of increasing concentrations of cholesterol,
which were chosen to mimic the biological environment
of the receptor. We used the MARTINI force field in our
study since it has been shown to be suitable for applications
such as membrane protein association (41–45) and parti-
tioning of membrane proteins between membrane domains
of varying compositions (46,47). Our results show that
cholesterol binds to transmembrane helix IV and has an
increased occupancy at that site, in both the monomeric
and dimeric regimes. Interestingly, our results show that
cholesterol occupancy modulates the dimerization process
of the receptor, altering the dimer structure and the helices
involved in the interface. These novel (to our knowledge)
results constitute one of the first reports to explore the
correlation between cholesterol’s association with the
receptor and its oligomerization and organization at a
molecular level.FIGURE 1 Schematic representation of the b2-adrenergic receptor. (a)
Top view of the receptor with individual helices marked. (b) Starting struc-
ture of the two monomers of the b2-adrenergic receptor in the POPC
bilayer. The two receptors are shown in shades of blue corresponding to
panel a; lipid molecules are shown in gray, the phosphate bead of lipid is
in orange, and the surrounding water molecules are in blue. (c) Time course
of dimerization of the b2-adrenergic receptor in POPC bilayers with
increasing cholesterol concentration. The minimum distance between two
receptors (defined as the distance between the closest beads from two
individual receptors, as shown in the figure) during the course of the
simulation is plotted for receptor association in POPC bilayers alone
(black); and in the presence of 9% (red), 30% (green) and 50% (blue)
cholesterol concentration. A representative simulation from each of the
four systems is plotted. See Materials and Methods for other details. To
see this figure in color, go online.MATERIALS AND METHODS
System setup
Molecular-dynamics simulations of the b2-adrenergic receptor embedded
in POPC membranes were carried out in the presence and absence of
cholesterol. The systems were represented using the MARTINI coarse-
grained force field (version 2.1) (48,49). A homology model of the b2-
adrenergic receptor (amino acid residues 29–342) was generated from
the crystal structure (29) (PDB: 2RH1) using SWISS-MODEL software
(50). The PDB structure 2RH1 is a chimera of the b2-adrenergic receptor
with the protein T4 lysozyme fused for crystallization. The homology
model was built by removing the T4 lysozyme part and replacing it
with the intracellular loop 3 of b2-adrenergic receptor. The atomistic
structure obtained was minimized and then mapped to its coarse-grained
representation. Bilayers containing POPC with increasing cholesterol con-
centration (0%, 9%, 30%, and 50%) were generated from an initial
conformation of randomly placed POPC, cholesterol, and water beads.
The bilayer formed in the simulation was equilibrated for 5 ms, leading
to uniform distribution of cholesterol in the bilayer. Details regarding
the number of lipids, cholesterol, and water used for each system are
given in Table S1 of the Supporting Material. Two copies of the
coarse-grained model of the b2-adrenergic receptor were inserted into
each of the equilibrated bilayers such that the interreceptor distance
(center of mass) was at least 6 nm (minimum distance of at least
3 nm). A top view of the b2-adrenergic receptor, in which the transmem-
brane helices are labeled, and the starting structure of a representative
simulation are shown in Fig. 1, a and b.Simulation parameters
All simulations were performed using the GROMACS simulation package,
version 4.5.4 (51). The cutoff for nonbonded interactions was 1.2 nm, with
electrostatic interactions shifted to zero in the range of 0–1.2 nm, and
Lennard-Jones interactions shifted to zero in the range of 0.9–1.2 nm. A
relative electrostatic screening of 15 was used. The temperature for each
group was weakly coupled using the Berendsen thermostat algorithm
(52) with a coupling constant of 0.1 ps to maintain a constant temperature
of 300 K during simulation. Semi-isotropic pressure was maintained usingthe Berendsen barostat algorithm (52) with a pressure of 1 bar indepen-
dently in the plane of the membrane and perpendicular to the membrane,
a coupling constant of 0.5 ps, and a compressibility of 3  105 bar1.
The time step used in the simulations was 20 fs. Simulations were rendered
using VMD software (53).Analysis
A transmembrane helix of a receptor was considered to be at the dimer
interface if it was within a cutoff of 0.5 nm of the other receptor. This
value was chosen based on the minimum distance of approach between
two beads in the MARTINI coarse-grained model (48,49). A lipid or
cholesterol molecule was defined to be bound to a particular transmem-
brane helix or amino acid residue (site) if it was within 0.5 nm of that
site. The maximum occupancy time was defined as the longest time a
given cholesterol molecule was bound at a particular site. The values
were normalized for all simulation lengths. A value of one implies that
the same cholesterol molecule was present at the site during the entire
simulation, and zero implies that cholesterol was never present at that
site. The binding region for POPC/cholesterol on a given helix was deter-
mined by calculating the distance map. The distance cutoff was 0.5 nm as
described above. The results showed no qualitative changes when a larger
cutoff of 0.6 nm was used.Biophysical Journal 106(6) 1290–1300
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The b2-adrenergic receptor dimerizes in the
membrane bilayer
To analyze the effect of cholesterol on dimerization of the
b2-adrenergic receptor, we carried out coarse-grained
molecular-dynamics simulations of the receptor in POPC
bilayers and POPC/cholesterol bilayers with increasing
cholesterol concentrations (9%, 30%, and 50%). Multiple
microsecond-timescale simulations were performed, for a
total simulation time of ~200 ms corresponding to ~800 ms
of effective time (atomistic simulation time) (48,49). Two
copies of the receptor were initially placed in a POPC bilayer
(with andwithout cholesterol) such that the interreceptor dis-
tance (center of mass) was at least 6 nm. Previous umbrella
sampling calculations (46) showed that the free energy of as-
sociation between two receptors is close to zero at a 1.5 nm
distance separation (minimum distance between receptors).
In our study, the receptors were initially placed at two times
this distance, i.e., with a minimum distance of 3 nm. The
initial setup of the system and the top view of the receptor
are shown in Fig. 1. During the course of the simulation,
the receptors diffused freely in the membrane and associated
with each other on a microsecond timescale. The minimum
distance between the two receptors during the course
of representative simulations in each case is shown in
Fig. 1 c. Several close associations were observed between
the two receptors before the final dimerized structure was
obtained. We calculated the phase space sampled by the
receptors in the monomer regime in one of the representative
systems (see Fig. S1). It is evident from the figure that all
orientations around the central receptor were sampled,
except for a narrow pathway leading to the central receptor.
The sampling of the receptors in the monomer regime dem-
onstrates that the dimer conformations were not biasedFIGURE 2 Schematic representation depicting the modulation of transmembra
increasing cholesterol concentration. (a and e) POPC bilayer. (b–d and f–h) PO
cholesterol. Representative top and side views of the transmembrane helices are
face are colored and labeled. The remaining helices are colored gray. See Mate
Biophysical Journal 106(6) 1290–1300according to the starting configurations, and adequate orien-
tational and translational sampling was achieved. The time
taken to form a stable dimer was variable and ranged from
2 to 15 ms. In most cases, the initial contact between two
receptors that led to a stable contact was made by intracel-
lular loops II and III. Several occurrences of the N-terminal
region and the C-terminal helix VIII were also observed at
the contact interface. Once the dimer was formed, it was
stable during the course of the simulation, although small
rearrangements of the two receptors relative to each other
were observed. The final interreceptor distance (i.e., the
distance between the center of mass of the two receptors in
the final dimer) was calculated to be ~3.2 nm.Dimer interface of the b2-adrenergic receptor in
the POPC bilayer
To further characterize the dimer structures, we analyzed the
transmembrane helices involved at the dimer interface. A
representation of the dimer interface (top and side views
of the transmembrane helices) is shown in Fig. 2, a and e.
Transmembrane helices IV and V from both receptors
were present at the dimer interface in POPC bilayers. The
simulations were repeated three times with different starting
velocities, and each time transmembrane helices IV and V
were observed to be present at the interface. A contact
map of all helix-helix contacts, normalized over the time
of occurrence, is shown in Fig. 3a. Since the most frequently
observed dimer interface involved symmetric interhelical
contacts, we termed such an interface a homo-interface
(i.e., the same transmembrane helices from both receptors
are involved at the dimer interface). In this conformation,
an increased accessibility to membrane lipids was observed
for transmembrane helices I and VII relative to transmem-
brane helices IV and V.ne helices of the b2-adrenergic receptor involved at the dimer interface with
PC bilayers containing 9% (b and f), 30% (c and g), and 50% (d and h)
shown for clarity. The transmembrane helices that comprise the dimer inter-
rials and Methods for other details. To see this figure in color, go online.
FIGURE 3 Contact maps depicting the helix-
helix interactions between the two receptors. (a)
POPC bilayer. (b–d) POPC bilayers containing
9% (b), 30% (c), and 50% (d) cholesterol. The
values were calculated as an average over all simu-
lations and normalized by the time of occurrence
and simulation length. A cutoff distance of 0.5 nm
was used to determine the contact residues. To see
this figure in color, go online.
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formed in POPC bilayers revealed the presence of a phos-
pholipid (POPC) molecule at the dimer interface (see
Fig. S2). The POPC molecule was present at the interface
in all three simulations. The binding of the POPC molecule
to the groove region formed by transmembrane helices IV
and Vof the interacting monomers occurred simultaneously
with the dimerization process. The POPC molecule re-
mained at the contact interface during the remaining simu-
lation time. Energetically favorable interactions with
several aromatic amino acid residues on transmembrane
helices IV and V were seen to stabilize the POPC molecule.Cholesterol modulates helices involved at the
dimer interface
Interestingly, the dimer interfaces observed in our simula-
tions with POPC bilayers were altered in the presence of
cholesterol. Fig. 2, b–d, show the progressive change in
the dimer interface with increasing concentrations of
cholesterol in the membrane. A contact map of the dimer
interfaces with varying concentrations of cholesterol is
shown in Fig. 3, b–d. In general, an increased presence of
transmembrane helices I and II was observed with
increasing cholesterol concentrations. We refer to an inter-
face containing different transmembrane helices from the
two receptors as a hetero-interface. The dimer interface in
membranes containing 9% and 30% cholesterol was most
often a hetero-interface, formed by transmembrane helices
I and II of one receptor and transmembrane helices IV
and V of the other. An example of a homo-interface wasalso observed in membranes containing 9% cholesterol
involving transmembrane helices IV and V. At 30% mem-
brane cholesterol, the rotation of the receptors around the
contact point led to the occasional involvement of the adja-
cent transmembrane helices III and VII. At 50% membrane
cholesterol, the dimer interface was formed mainly by
transmembrane helices I and II from both receptors (see
Fig. 2, d and h). A snapshot of the final dimer structure is
shown in Fig. S3. The adjacent transmembrane helix VII
was also observed to be occasionally involved at the dimer
interface due to rotation of the receptors around the contact
point (see Fig. 3 d). In this conformation, the C-terminal
helix VIII was also occasionally found to be present at
the dimer interface. The results obtained were consistent
for the three replicate simulations performed. Taken
together, these results show that the presence of cholesterol
in the membrane increases the involvement of trans-
membrane helices I and II, and restricts the presence
of transmembrane helix IV at the dimer interface of the
b2-adrenergic receptor. This observation could have poten-
tial implications for designing drugs for GPCR targets (see
below).Cholesterol occupancy at transmembrane helix IV
restricts its involvement in the dimer interface
To understand whether a direct receptor-cholesterol interac-
tion or indirect effects (such as the alteration of membrane
properties) are responsible for the modulation of the dimer
interface with increasing membrane cholesterol content,
we analyzed cholesterol density around the transmembraneBiophysical Journal 106(6) 1290–1300
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the receptor, analyzed over several z slices, is shown in
Fig. S4. We identified three sites of high cholesterol density
in the outer leaflet and four sites in the lower leaflet. Impor-
tantly, we identified a site on transmembrane helix IV with
the highest density in the middle of the bilayer. Although a
few hot spots of interactions could be identified, very few
unbinding events at the highest density sites were observed
since the cholesterol occupancy at these spots was of the
order of microseconds. In the absence of sampling (i.e., in
the absence of adequate binding/unbinding events at all
interaction sites), measures based on population densities
will necessarily be biased. To exclusively account for spe-
cific binding events, we calculated the maximum occupancy
time of cholesterol around each of the transmembrane heli-
ces during the simulation. We defined the maximum occu-
pancy time as the maximum time a given cholesterol
molecule was continuously bound to a given site, normal-
ized to the simulation length. A value of one implies that
the cholesterol molecule was present at the given site
throughout the entire simulation time, and zero implies it
was never present at that site. The simulations were dividedBiophysical Journal 106(6) 1290–1300into two regimes: the first corresponding to monomeric
receptors and the second corresponding to the receptor
dimers. The maximum occupancy time of cholesterol
around the transmembrane helices averaged over the three
replicates performed for each cholesterol concentration is
shown in Fig. 4. In general, we observed the longest occu-
pancy of cholesterol at transmembrane helix IV. In the
monomeric regime (Fig. 4, a, c, and e), the maximum occu-
pancy at transmembrane helix IV increased with increasing
cholesterol concentration. At the highest cholesterol con-
centration (50%), the maximum occupancy of cholesterol
at transmembrane helix IV was considerably higher than
in other transmembrane helices (Fig. 4, e and f). Taken
together, these results point to a cholesterol-binding site
on transmembrane helix IV whose occupancy is stochastic
and dependent on the membrane cholesterol concentration.
In the absence of several binding/unbinding events, the
highest-occupancy sites observed in our simulations
compare well with the highest-density sites, but need not
correspond to binding sites with large favorable free energy.
Interestingly, the increased presence of a cholesterol
molecule at transmembrane helix IV in the monomericFIGURE 4 Cholesterol occupancy at the b2-
adrenergic receptor (maximum occupancy time of
cholesterol, i.e., the maximum time a given choles-
terol molecule was continuously bound to each of
the transmembrane helices). (a–f) The values
shown are normalized and averaged for three simu-
lations at increasing cholesterol concentrations: 9%
(a and b), 30% (c and d), and 50% (e and f). The
simulations were divided into two regimes: the
monomer regime (a, c, and e) and the dimer regime
(b, d, and f). A maximum occupancy time of one
implies that a given cholesterol molecule was
present at the given site throughout the entire simu-
lation time, and a value of zero implies it was
always absent from that site. The error bars repre-
sent the Standard Deviation (SD) between the sim-
ulations. See Materials and Methods for further
details. To see this figure in color, go online.
Cholesterol and Receptor Dimerization 1295regime correlated well with the decreased presence of this
helix at the final dimer interface. At 50% membrane choles-
terol concentration, the maximum occupancy of cholesterol
at transmembrane helix IV was much higher than at 9%
cholesterol, and a lower involvement of transmembrane helix
IV was observed at the dimer interface. At 9% and 30%
membrane cholesterol concentrations, the occupancy of
cholesterol at transmembrane helix IV was usually higher
in one of the receptors compared with the other, and in gen-
eral a hetero-interface involving transmembrane helices I and
II from one receptor and transmembrane helices IV and V
from the other was observed (see Fig. 3, b and c). At 9%
cholesterol concentration, a single instance of homo-
interface involving only transmembrane helices IV and V
was observed. Analysis of that individual trajectory showed
that the cholesterol occupancy around transmembrane helix
IV in the monomeric regime was very low in both receptors
under that condition. We therefore hypothesize that a high
occupancy of cholesterol at transmembrane helix IV, i.e., a
stable occupancy of cholesterol at that site, interferes with
its subsequent participation in dimer interface formation.FIGURE 5 Cholesterol-binding sites on transmembrane helix IV of the
b2-adrenergic receptor. (a) The CCM site observed in the crystal structure
(30). (b) The cholesterol-binding site identified in the coarse-grained
simulations that directly corresponds to the CCM site. (c–f) A high
dynamics was observed for the cholesterol and additional conformations
of the cholesterol near the site. The backbone of transmembrane helix IV
is shown in blue, and the side chains of the amino acid residues R151,
I154, and W158 are shown in gray. The bound cholesterol molecule is
shown in magenta and the polar bead representing the -OH group is
depicted in blue. For clarity, the surrounding receptors, lipid, cholesterol,
and water molecules are not shown. See Materials and Methods for further
details. To see this figure in color, go online.Cholesterol occupancy site at transmembrane
helix IV
To explore the molecular details of the cholesterol occu-
pancy site at transmembrane helix IV, we calculated a resi-
due-based distance map between the bound cholesterol and
the amino acid residues on transmembrane helix IV. A high
dynamics was observed at the site and a few representative
snapshots are depicted in Fig. 5. One of these sites (Fig. 5, a
and b) corresponds to the CCM site reported in the crystal
structure (30). This site is at amino acid residues R151,
I154, and W158 (the corresponding Ballesteros-Weinstein
numbers are given in Table S2). The cholesterol molecule
diffuses on a microsecond timescale (Fig. 5, c–f) to sample
site m1 (as defined in Fig. S4) at amino acid residues W158
and I159. In the first site, the polar bead of the cholesterol
molecule (modeling the terminal hydroxyl group), interacts
with the charged residue R151. At site m1, the polar bead
interacts mainly with the aromatic residue W158. The
nonpolar beads of the cholesterol molecule interact mainly
with nonpolar amino acid residues, such as I153, I154,
V157, and I159. Although the most favorable interaction
between the cholesterol molecule and the receptor occurs
on transmembrane helix IV, several contacts are also
observed with the adjacent transmembrane helices II and III.POPC binding site at the dimer interface
As discussed above, the final dimer structures formed in
POPC bilayers revealed the presence of a phospholipid
molecule at the dimer interface (see Fig. S2). The binding
of the POPC molecule at the dimer interface was also
observed at 30% and 50% membrane cholesterol. Due tothe variation in the transmembrane helices present at the
interface in the absence and presence of cholesterol, we
could not discern any consensus sequence. Two such
POPC-binding sites are shown in Fig. S5 and correspond
to the bilayers of POPC and POPC/30% cholesterol. The
zwitterionic headgroup of the POPC interacts with either a
charged residue such as E225 or polar aromatic residues
such as Y199. The fatty acyl chain of the phospholipid
molecule interacts mainly with nonpolar residues such as
I205 or aromatic residues such as F217.DISCUSSION
GPCR organization represents a crucial determinant in
cellular signaling (54). The heterogeneous distribution of
GPCRs in membrane domains characterized by different
lipid compositions has given rise to new challenges andBiophysical Journal 106(6) 1290–1300
1296 Prasanna et al.complexities in receptor signaling. Therefore, cellular
signaling has to be considered in the context of organization
of various signaling components, including receptors, lipids,
and G-proteins. In this context, several questions remain un-
explored regarding the molecular details of receptor associ-
ation and oligomerization. In this work, we analyzed the
effect of membrane cholesterol on the dimerization of the
b2-adrenergic receptor. The novel (to our knowledge) aspect
of our work stems from the fact that we correlated the mo-
lecular-level receptor-cholesterol interaction with modula-
tion of the receptor dimerization process. We performed
multiple microsecond-timescale, coarse-grained simula-
tions that allowed us to explore the interface for receptor
dimers in lipid bilayers at several cholesterol concentra-
tions. We showed that cholesterol modulates the dimer
interface of the b2-adrenergic receptor by binding to a
cholesterol occupancy site on transmembrane helix IV.FIGURE 6 Comparison of the dimer interfaces of the b1-adrenergic
receptor and the b2-adrenergic receptor. (a and b) Crystal structure of the
b1-adrenergic receptor (83). (c and d) Dimer structures of the b2-adrenergic
receptor obtained from coarse-grained simulations at 0% and 50% choles-
terol concentration, respectively. The transmembrane helices that comprise
the dimer interface are colored and labeled. The remaining helices are
colored gray. To see this figure in color, go online.Exploring the energy landscape by unbiased
simulations
It is difficult to explore the complex energetics of GPCR
organization due to the limited methodologies available to
probe these processes. Unbiased atomistic molecular-
dynamics simulations have been used extensively to probe
protein and membrane dynamics that occur on the nano-
second timescale (33,34,55–62). With increasing computa-
tional power, unbiased atomistic simulations have been
used to study phenomena on the microsecond timescale
(63–65). Unbiased coarse-grained simulations are increas-
ingly being used to explore microsecond-timescale
dynamics and organization (66–72). In particular, coarse-
grained simulations using unbiased sampling have improved
our understanding of GPCR association (41,73). Although
unbiased molecular-dynamics simulations can better repre-
sent the equilibrium evolution of the system without any
external bias (potential/force) or reaction coordinate, they
are limited by the phase space they sample (64,74). Biased
simulations such as umbrella sampling and force pulling are
often performed to improve sampling, and with careful anal-
ysis can be used to estimate the underlying unbiased true en-
ergy landscape. In two previous studies, these methods were
employed to calculate a potential of mean force (PMF) of
GPCR association along a given reaction coordinate (inter-
helical distance) (43,75). In both studies, a 1D PMF was
calculated for only limited dimer interfaces (e.g., a 1/7 inter-
face) and the sampling of the other dimer interfaces was
absent. Importantly, recent work suggested that even for
the association of single transmembrane helices, 1D PMFs
result in limited sampling and overestimate the energetics
(76–78). The limited sampling arises from slow membrane
dynamics, and biased simulations of membrane partitioning
were recently shown to over- or underestimate the underly-
ing (unbiased) energy landscape (79–81). Consequently, it
still remains difficult to achieve a complete thermodynamicBiophysical Journal 106(6) 1290–1300understanding of GPCR association in different membrane
compositions. In this work, we carried out multiple unbiased
coarse-grained simulations totaling ~1 ms to analyze the
association between two GPCRs and probe the role of the
membrane lipid environment. The membrane’s effects in
driving and modulating receptor association within mem-
branes have been usually neglected and the focus of our
work is to understand these effects.The dimer interface and comparison with
experimental data
Most studies of the dimer interface of the b2-adrenergic
receptor have employed indirect methods, and several dimer
interfaces have been proposed (39,82). Interfaces involving
transmembrane helix VI (39) or helix VIII (82) have been
proposed based on results obtained by different techniques.
The most direct evidence for dimer interfaces comes from
the related b1-adrenergic receptor (83). The crystal structure
of the ligand-free basal structure of the b1-adrenergic recep-
tor shows two distinct dimer structures: one involving trans-
membrane helices I and II and helix VIII, and the other
involving transmembrane helices IV and V. The two dimer
interfaces observed in the crystal structure correspond to
the two homo-interfaces observed in our simulations (see
Fig. 6), and no crystal contacts were observed that corre-
spond to the hetero-interface. However, we propose that
although both dimer interfaces are energetically favorable,
the membrane environment (cholesterol) tunes the ener-
getics to modulate the relative populations.Structural plasticity of the dimeric interface
The various dimer interfaces of the b2-adrenergic receptor
revealed by various experimental methods (39,82,83)
Cholesterol and Receptor Dimerization 1297suggest that the energetics of association via the different
dimer interfaces are comparable and perhaps dependent on
the experimental conditions. In a recent biased molecular-
dynamics simulation of the b2-adrenergic receptor, Johnston
et al. (75) calculated the energetics of two interfaces and re-
ported comparable stabilities for these two dimer interfaces.
Although the dimer interfaces they considered were distinct
from those observed in this report, their results confirmed a
structural plasticity in the dimer structure. Similarly, rela-
tively weak binding energetics was recently reported for
different rhodopsin dimer interfaces and suggested to be
relevant in the context of the supramolecular organization
of GPCRs (43). Our data suggest a similar plasticity of the
dimer interface for the b2-adrenergic receptor, further
modulated by the membrane cholesterol. A total of 49 orien-
tations are possible, considering a simple interaction matrix
between the seven transmembrane helices. In our set of 12
simulations, several of these interfaces were sampled. To
test the plasticity and relative stabilities of the dimer inter-
faces, we performed 10 additional shorter simulations at
each cholesterol concentration. A comprehensive contact
map with the increased sampling is shown in Fig. S6. The
highest-population interfaces correspond to the most stable
interfaces observed in the first set of simulations, i.e., a
homo-interface involving transmembrane helices IV and V,
a hetero-interface with transmembrane helices IV and V,
and I and II, and another homo-interface involving trans-
membrane helices I and II. The plasticity in the dimer inter-
faces can be easily appreciated in terms of the relative
populations of interfaces observed in the contact maps.
Since the plasticity emerges from the comparable energetics
of the interfaces, the modulation of the energetics by the
environment results in changes in the relative populations
of these interfaces.Cholesterol occupancy sites
Lipid-receptor interactions are especially significant for
GPCRs because they undergo conformational changes to
carry out their function, giving rise to structural plasticity
(84,85). These cooperative conformational changes involve
the participation of surrounding lipid molecules, and various
conformations are stabilized by the binding of different
lipids. One of the first reports of a cholesterol-binding site
in GPCRs was based on the crystal structure of the b2-adren-
ergic receptor (29,30), in which a stably bound cholesterol
was reported. It should be noted that GPCRs are known to
behave differently in cubic and lamellar lipidic mesophases
(86), and the cholesterol-binding site, termed the cholesterol
consensus motif (CCM), could be specific to the membrane
lipid environment. Interestingly, one of the binding modes
of cholesterol at helix IV we observed in our coarse-grained
simulation correlates well with the CCM site reported in the
crystal structure (30), indicating that cholesterol occupancy
at this site is independent of the lipid packing arrangement(see Fig. 5). Cholesterol occupancy on helices V and VII,
which contain another putative cholesterol-binding site
(the CRAC motif (87)), is also relatively high, but much
lower than on helix IV. These results are consistent with
the dynamic nature of cholesterol binding to GPCRs
predicted from previous molecular-dynamics studies
(32–34). High occupancy of cholesterol at this site on helix
IV was observed in both monomer and dimer states. More
importantly, our results show that cholesterol occupancy at
this site leads to modulation of the final dimer structures
obtained. As stated above, this implies that the underlying
energy landscape of receptor dimerization, i.e., the relative
stabilities of these dimer interfaces, can be modulated by
interaction with membrane cholesterol.Functional significance of cholesterol-mediated
dimer interfaces
The b2-adrenergic receptor was recently cocrystallized
with the stimulatory G-protein (Gs), and the receptor-Gs
protein interface was shown to be formed by transmem-
brane helices V and VI (88). Although monomers of the
b2-adrenergic receptor were reported to be sufficient for
signaling (40), the receptor was demonstrated to be present
as a dimer in vivo (38), and receptor organization was
shown to be important for its function (39). If the recep-
tor-Gs protein interaction includes a receptor dimer, the
dimer interface observed in our simulations in POPC
bilayers could lead to potential steric hindrance with the
Gs protein since it involves transmembrane helix V. In
the presence of increasing membrane cholesterol, trans-
membrane helix V from either one receptor or both recep-
tors becomes progressively available for association with
the Gas subunit. We speculate that in the altered dimer
conformation in the presence of cholesterol, the b2-adren-
ergic receptor dimer can interact more favorably with the
Gas subunit. Due to the comparable energies of the
different dimer interfaces of b2AR (43,75), the dimer
interfaces observed in our simulations in the presence
and absence of cholesterol only represent the most popu-
lated dimer interfaces and it is possible that other dimer
conformations could be sampled under different condi-
tions. To the best of our knowledge, our results constitute
the first report of the modulation of the dimeric structure
of a GPCR by the membrane cholesterol.
Knowledge about GPCR dimer models would allow the
development of dimeric or bivalent drugs that could interact
with both monomers in a dimer, and open up new possibil-
ities in drug discovery (11). The modulation of GPCR dimer
structure by membrane cholesterol could have interesting
and far-reaching applications in cellular physiology and
drug discovery. Cellular cholesterol is known to be develop-
mentally regulated and its content increases with aging
(89,90). This could imply that the organization of GPCR
oligomers is age dependent. The efficacy of a specificBiophysical Journal 106(6) 1290–1300
1298 Prasanna et al.drug designed to target a GPCR dimeric interface could
therefore change with the process of aging. Interestingly,
the membrane lipid environment of GPCRs has been impli-
cated in disease progression during aging (91). In addition,
there is a strong asymmetry in the manner in which choles-
terol is distributed among various organs and tissues in the
human body. In other words, the distribution of cholesterol
among various tissues is not uniform. The central nervous
system, which accounts for only ~2% of the body mass,
contains ~25% of the free cholesterol present in the whole
body (92). This means that GPCR oligomerization could
be tissue specific. With the development of new techno-
logies to detect GPCR oligomers in native tissues (10),
this could represent an exciting possibility. Importantly,
the fact that the same GPCR could be present in multiple
tissues may pose a considerable challenge in designing
drugs suitable for the dimer interface.
In conclusion, using multiple coarse-grained simulations
of the b2-adrenergic receptor in membranes with varying
lipid composition, we have shown that the dimerization
process of the b2-adrenergic receptor is modulated by mem-
brane cholesterol. More specifically, we showed that choles-
terol occupancy at transmembrane helix IV restricts its
involvement at the dimer interface and stabilizes a dimer
interface with transmembrane helices I and II instead of
transmembrane helices IV and V. Based on our results, it
appears that dimer plasticity is relevant not just as an orga-
nizational principle but also as a regulatory principle for
GPCR function. Understanding the cross talk between
GPCRs and cholesterol represents an important step in our
overall understanding of GPCR function in health and
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